explore -WSS

explore

author：comprehensive 2025-10-01 17:05:52 - browse：876

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Readout Newsletter: BridgeBio, Akero, and human embryo models

hotspot

WSS

Lack of health data on LGBTQ+ people has serious consequences

WHO may add ‘noma' to its list of neglected tropical diseases

Senate panel to vote on hospitals, PBMs, prisoner care

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Chimpanzees, like humans and whales, get menopause: Study

A new approach to psychiatric drug development

entertainment

explore

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Immune cells and nerve overgrowth may explain recurring UTI pain

Malaria cases in Florida and Texas: Here’s what you need to know

$1 billion proposal to grow Boston, Massachusetts biotech

Activists slam private health insurers over coverage restrictions

Harvard's David Sinclair gets blowback over aging

What does generative AI mean for health care? We asked experts

He's 19 months old and has one of the world’s rarest diseases

New air purifier tech could be key to improving indoor air quality

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

leisure time

Telehealth options flood the market as retailers push virtual care

Microsoft's Peter Lee: Generative AI could help doctors be more human

Telehealth options flood the market as retailers push virtual care

Diversifying clinical trials isn't enough to close racial gaps: study

Ancient Greek ideas underpin modern concepts of pregnancy

CDC recommends rationing of RSV shot due to shortages

focus

hotspot

hotspot

leisure time